Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 578 of 5804
-
New CAR-T therapy targets tough lymphoma in early trial
Disease control OngoingThe goal of this multicenter study is to test JNJ-90009530 in Relapsed or Refractory Non-Hodgkin Lymphoma Patients. The main questions the study aims to answer are: * can a dose of JNJ-90009530 be determined that is safe and well tolerated by patients. * will JNJ-90009530 help p…
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for kids with severe colitis: oral drug trial launches
Disease control OngoingUlcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how safe and effective Upadacitinib is in treating pediatric participants with UC. Adverse event…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New combo therapy shows promise for rare chest cancer
Disease control Recruiting nowThe aims of this study are to verify the feasibility, effectiveness, and safety of the combination of enrolizumab and radiotherapy for neoadjuvant treatment for locally advanced thymic carcinoma, and to provide recommendations for the establishment of unified evaluation criteria …
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy targets liver cancer in clinical trial
Disease control OngoingThe objective of the ROWAN clinical study is to assess the efficacy of local tumor control in HCC patients who receive TheraSphere followed by durvalumab and tremelimumab.
Phase: PHASE2 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Virus injection takes on deadly brain tumor in new trial
Disease control Recruiting nowThis clinical trial aims to evaluate whether an oncolytic viral agent can treat recurrent glioblastoma. It will also assess the safety and tolerability of the oncolytic viral agent. The primary question it seeks to answer is: What medical problems do participants experience when …
Phase: PHASE1, PHASE2 • Sponsor: Mianyang Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New study tests common antidepressant for PTSD in military and civilian groups
Symptom relief TerminatedThis is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PTSD utilizing an adaptive platform trial design. Participants are randomized among the available cohorts in the study and the result…
Phase: PHASE2 • Sponsor: Global Coalition for Adaptive Research • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New pill aims to steady shaking hands in essential tremor trial
Symptom relief OngoingThe goal of this clinical study is to compare ulixacaltamide and placebo treatment in essential tremor. The main question it aims to answer is: • Is ulixacaltamide a safe and efficacious treatment for patients with essential tremor? Participants will be asked to participate in …
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could gut bacteria help fight prostate cancer? new trial tests antibiotic combo
Disease control Recruiting nowPROMIZE is an open-label, multi-centre, single-arm, Phase I/II clinical trial, evaluating the safety, tolerability and anti-tumuor efficacy of an antibiotic combination and enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC).
Phase: PHASE1, PHASE2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Immunotherapy combo shows promise in colorectal cancer fight
Disease control Recruiting nowThe goal of this clinical trial is to compare the efficacy and safety of the combination of immune checkpoint inhibitors (ICIs) and FOLFOX regimen compared to FOLFOX regimen alone in the neoadjuvant chemotherapy of locally advanced colorectal cancer. The main question aims to ans…
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New pill takes on brain tumors and metastases in early trial
Disease control Recruiting nowThis multi-site, Phase 1/2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO212 alone for the treatment of patients with radiographically-confirmed progression of Astrocytoma IDH- mutant, Glioblastoma ID…
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Stem cell mobilization offers new hope for uterine scarring and infertility
Disease control Recruiting nowThis study will assess the use of autologous bone marrow stem cells mobilization using 1,1'-\[1,4-phenylenebis-(methylene)\]-bis-1,4,8,11-tetraazacyclotetradecane (PLERIXAFOR) as an effective medical therapy for the treatment of Asherman's Syndrome (AS), Atrophic Endometrium (AE)…
Phase: EARLY_PHASE1 • Sponsor: Hugh Taylor • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New combo vaccine targets two respiratory viruses in seniors
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to assess the safety and immunogenicity of a single intramuscular (IM) injection of different doses of an respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) vaccine candidate, in adult participants aged 60 years and older. In addition,…
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:01 UTC
-
Mass malaria treatment trial aims to wipe out hidden infections in ghanaian communities
Disease control Recruiting nowPrevious malaria control studies in Ghana have shown that community-wide approaches can substantially reduce malaria infections. In a mass testing, treatment and tracking (MTTT) study, more than 75% of people in target communities were reached, leading to a 24% reduction in asymp…
Phase: NA • Sponsor: Noguchi Memorial Institute for Medical Research • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a One-Hour chat help teens at risk for suicide?
Symptom relief CompletedThe current study is a clinical trial, meaning a research study in which human subjects are prospectively assigned to one or more interventions to evaluate the effects of those interventions on health-related behavioral outcomes. Specifically, male and female adolescents with cur…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Promising combo aims to boost remission in follicular lymphoma
Disease control OngoingThe goal of this study is to learn about the safety and effectiveness of the combination of tazemetostat pills in combination with mosunetuzumab injections for people with follicular lymphoma who haven't received treatment before. The investigators hypothesize that tazemetostat w…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Custom immune cells take on advanced colorectal cancer in early trial
Disease control Recruiting nowThe primary objective of this study is to evaluate the feasibility, safety, and efficacy of personalized T-cell therapy based on tumor neoantigens in patients with advanced colorectal cancer, so as to provide a novel individualized therapeutic strategy for such patients.
Phase: PHASE1 • Sponsor: Ying Yuan, MD • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Magnetic brain pulses aim to quiet suicidal urges
Disease control CompletedThis neuroimaging study is a clinical trial investigating the effectiveness of intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) in reducing suicide risk in patients with major depressive episode (MDE) or borderline person…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New 'Four-in-One' antibody takes on tough lymphoma
Disease control Recruiting nowPhase I main objectives: To observe the safety and preliminary efficacy of GNC-035 in patients with relapsed/refractory non-Hodgkin lymphoma and other hematological malignancies, to determine the DLT and MTD, or MAD, and to determine RP2D. Phase II Main objective: To explore the …
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Promising new eye treatment could halt vision loss from keratoconus
Disease control CompletedA Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Phase: PHASE3 • Sponsor: Epion Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New universal CAR t therapy targets tough blood cancers
Disease control Recruiting nowThe purpose of this clinical trial is to assess the feasibility, safety and efficacy of universal CAR T cells based on 4SCAR7U design against CD7-positive hematological malignancies using CD7 specific universal CAR T cells. The study also aims to learn more about the function of …
Phase: PHASE1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC